|
|
||||||||
Correspondence to:
Gert M. Kostner
LP[a] is one of the most atherogenic lipoproteins consisting of an LDL-like core particle and a covalently linked glycoprotein of variable size. Due to its structural features, its heterogeneity and instability, there are great difficulties in standardizing quantitative immunochemical Lp[a] assays. One particular problem is the preparation of a pure primary standard, which is sufficiently stable to be used for value assignment of secondary reference material. Here we describe a method to purify Lp[a] to virtual homogeneity. When mixed with glycerol at a ratio of 1:1, the preparation is stable in the deep frozen state for more than 12 months. This latter material gave dose;response curves in several immunochemical assays that were parallel to fresh or frozen sera, freshly prepared Lp[a], and other proposed reference materials. After determination of the protein content by amino acid analysis, it was possible to assign concentrations in molar and mass units to these preparations considering the theoretical molecular weights of the particular apo[a] isoform.
Thus we propose to use this procedure for preparation of a "gold standard" for Lp[a] assays.Kostner, G. M., A. Ibovnik, H. Holzer, and H. Grillhofer. Preparation of a stable fresh frozen primary lipoprotein[a] (LP[a]) standard. J. Lipid Res. 1999. 40: 2255;2263.
Supplementary key words:
DELFIA, LDL, ELISA, glycerol
Copyright © 1999 by Lipid Research, Inc.
Original Article
Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard
Gert M. Kostnera,
Anton Ibovnika,
Herwig Holzerb, and
Harald Grillhofera
a Institute of Medical Biochemistry, University of Graz, Harrachgasse 21, 8010 Graz, Austria
b Department of Nephrology and Hemodialyses, Auenbruggerplatz 15, 8036 Graz, Austria
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Osibow, R. Malli, G. M. Kostner, and W. F. Graier A New Type of Non-Ca2+-buffering Apo(a)-based Fluorescent Indicator for Intraluminal Ca2+ in the Endoplasmic Reticulum J. Biol. Chem., February 24, 2006; 281(8): 5017 - 5025. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Simo, J. Camps, E. Vilella, F. Gomez, A. Paul, and J. Joven Instability of Lipoprotein(a) in Plasma Stored at -70 {degrees}C : Effects of Concentration, Apolipoprotein(a) Genotype, and Donor Cardiovascular Disease Clin. Chem., September 1, 2001; 47(9): 1673 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schulter, P. Koolwijk, E. Peters, S. Frank, A. Hrzenjak, W. F. Graier, V. W. M. van Hinsbergh, and G. M. Kostner Impact of Apolipoprotein(a) on In Vitro Angiogenesis Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 433 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Buechler, H. Ullrich, M. Ritter, M. Porsch-Oezcueruemez, K. J. Lackner, S. Barlage, S. O. Friedrich, G. M. Kostner, and G. Schmitz Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes Blood, February 15, 2001; 97(4): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |